David Chang steps up to CEO spot at WuX­i's cell and gene ther­a­py CD­MO; David Meline is the new CFO at Mod­er­na

→ David Meline didn’t stay re­tired for long. As re­port­ed yes­ter­day, the for­mer Am­gen ex­ec will re­place Lorence Kim as CFO of Mod­er­na as the Big Phar­ma has sprint­ed to the front of the Covid-19 vac­cine pack, get­ting se­lect­ed as one of the fi­nal­ists for Op­er­a­tion Warp Speed. Meline, who gets start­ed on Mon­day, an­nounced his re­tire­ment as Am­gen’s CFO in Oc­to­ber 2019, re­main­ing in the role un­til the end of the year. But he’s back in the sad­dle at a cru­cial time as Mod­er­na pre­pares for Phase III stud­ies of their SARS-CoV-2 vac­cine. Meline pre­vi­ous­ly held lead­er­ship po­si­tions at 3M and Gen­er­al Mo­tors.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER